SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-20-002937
Filing Date
2020-02-18
Accepted
2020-02-18 17:29:40
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 navb20200218_424b5.htm 424B5 386689
2 a4.jpg GRAPHIC 12829
3 navb20200218_424b5img001.jpg GRAPHIC 5858
  Complete submission text file 0001437749-20-002937.txt   413676
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-222092 | Film No.: 20626537
SIC: 2835 In Vitro & In Vivo Diagnostic Substances